Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesModerate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review
Intensive Care Medicine, 10/28/09
Dmello D et al. – Limited data exist concerning the safety and efficacy of moderate hypothermia and ICP monitoring for the treatment of ICH in acute liver failure. The available evidence shows that induction of moderate hypothermia in this clinical setting is feasible and possibly efficacious. Well–designed prospective clinical trials are warranted in this challenging context, given the potential of providing a bridge to liver transplantation or even clinical recovery.
Dayton Dmello, 10/28/09
| Moderate hypothermia in acute liver failure represents an exciting but challenging aspect of a therapeutic paradigm for the treatment of intracranial hypertension. We seek to allay the apprehension that accompanies the utilization of moderate hypothermia as a therapeutic modality in this clinical setting, fully aware that large-scale randomized trials are needed to better define its long-term effectiveness and utility. Morever, we fully understand the risks involved with concomitant intracranial pressure monitoring, but are cautiously optimistic that the benefits outweigh the risks, based on limited available data from our review. Finally, we also firmly believe that there needs to be an acceptance of this paradigm into the algorithm of acute liver failure management, as this would provide much-needed answers regarding its potential role as a bridge to hepatic regeneration and clinical recovery. |
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Liver disease: Early signs you may be missing
APCToday, 10/21/09
Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09
Severe sepsis in cirrhosis
Hepatology, 11/04/09
Sponsor
Article Search
Sponsor